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Among the disadvantages of smear microscopy for detection of tuberculosis cases is its
inability to differentiate between Mycobacterium tuberculosis (MTB) and non-tuberculous
mycobacteria (NTM). This study evaluated two, new immunochromatographic assays –
Capilia TB-Neo and SD Bioline – on unheated and heated cultures at 80 C for 30 min
respectively for their ability to discriminate between MTB complex and NTM as compared
with the molecular Genotype assay. Mycobacteria used in the study were obtained from
smear-positive specimens collected from patients at four major hospitals in Cross River
State, Nigeria. Capilia TB-Neo and SD Bioline showed sensitivities of 98.8% and 93.8%
respectively and 100% specificity for both assays. Heating the isolates did not significantly
impact the test performance. Both tests are recommended for use in rapid differentiation
of strains isolated in Nigeria.
 2013 Asian-African Society for Mycobacteriology. All rights reserved.Introduction
The rise in HIV infections and the neglect of tuberculosis (TB)
control programs have enabled the resurgence of TB [1].
Tuberculosis caused by Mycobacterium tuberculosis [MTB] is a
major disease of great public health concern. There were 9.4
million new TB cases in 2009, including 1.1 million cases
among people with HIV (http://www.who.int/tb/publica-
tions/2010/factsheet_tb_2010.pdf). The highest incidence
rates in Africa are in South Africa and Nigeria, with the latter
having an estimated 460,000 new cases per year [2]. Basic
diagnosis of TB has not changed for more than a century;
therefore, finding simple, quick tests is a priority and remains-African Society for Myco
nt of Medical Laboratory
37 77358743.
Pokam).a major challenge to fighting TB (http://www.stoptb.org/re-
sources/factsheets/fastfacts.asp).
Although in regions where TB is highly prevalent as in
Nigeria, most culture-positive mycobacteria are of the MTB
complex. Globally, non-tuberculous mycobacteria (NTM) iso-
lates have been increasing gradually [3]. NTM trigger diseases
and true infections and thus can be important clinically [4].
Data on NTM disease in sub-Saharan Africa are limited, ow-
ing mainly to the lack of culture facilities, as well as the com-
plexity of identification methods for mycobacterial species.
As a result, many laboratories do not discriminate between
MTB and NTM [5–7], and treatment in most African countries,
including Nigeria, relies on sputum smear microscopy. Thebacteriology. All rights reserved.
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first-line anti-tuberculous drugs [7,8], thereby worsening the
patient‘s condition and increasing the risk of drug resistance.
The acid-fast bacterium is known to produce 200 or more
kinds of protein, and MTB has been known to secrete more
than 33 different proteins [9]. The mycobacterial antigen
MPB64, isolated from culture filtrates of Mycobacterium bovis
BCG since 1984, and detected by the immunochromatograph-
ic method was later confirmed by gene-based analysis to be
identical to MPT64 produced by MTB. NTMs do not produce
MPB64. This secreted mycobacterial protein has been used
for diagnostic purposes, and is found in unheated culture
media of MTB, M. bovis, and some but not all substrains of
M. bovis BCG [10–15].
In an attempt to assess the sensitivities and specificities of
two immunochromatographic techniques in the differentia-
tion of MTB and NTM and their usage on strains isolated in
Nigeria, Capilia TB-Neo and SD Bioline kits were used on both
unheated and heat-killed cultures, respectively, and com-
pared with the Genotype assay.
Materials and methods
The study was carried out in Cross River State, located in the
southern region of Nigeria. Subjects included 97 sputum
smear-positive patients of both sexes, from all age groups
seen in the major hospitals and TB care facilities of the north-
ern, central and southern senatorial districts of the State.
Sputum specimens obtained from patients were preserved
using sodium carbonate (75 mg), and refrigerated until
cultured.
Specimens were decontaminated using the modified Petr-
off method, and cultured using BACTEC 960. Smears were
made from isolates obtained from the BACTEC MGIT tubes,
stained by the Ziehl Neelsen staining method, and examined
for the presence of Acid Fast Bacilli (AFB).
The growth on AFB positive MGIT tubes was further inoc-
ulated into the Lowenstein–Jensen slants where pure cultures
were obtained. Recovery of the organisms and identification
using Capilia TB-Neo (TAUNS Laboratories, Inc., Japan) was
performed according to manufacturer’s instructions (http://
capilia.jp/english/capilia_tb_neo.html).
A turbid suspension for each isolate was prepared using
1 ml of distilled water and approximately 3 loopsful of bacteria
from Lowenstein–Jensen media, The bacteria were heat-killed
in a water bath at 80 C for 30 min, preserved at 80 C until
tested using SD Bioline according to manufacturer’s instruc-
tions (Standard Diagnostics, Inc., Yongin, Korea).
To determine the species of the isolates, the Genotype
Mycobacterium CM kit was used according to manufacturer’s
instructions (Hain Lifescience GmbH, Nehren, Germany).Results
A total of 97 strains were isolated on Lowenstein–Jensen med-
ium and tested for the presence of the mycobacterial protein
using both kits; 76 were positive for both Capilia and SD Bio-
line, while 17 were negative. On the other hand, 4 SD Bioline
negative isolates were Capilia positive, bringing Capilia posi-tive isolates total to 80 (Table 1). Further identification of all
the isolates was carried out using Hain (Table 2). Eighty Cap-
ilia positive isolates were identified as members of the MTB
complex, and one isolate of the 17 Capilia negative was also
identified as a member of the MTB complex (Sensitiv-
ity = 98.8%). On the other hand, 5 SD Bioline negative isolates
were identified as members of the MTB complex (Sensitiv-
ity = 93.8%). No false positive results were obtained using both
tests (Specificity = 100%).Discussion
This study has shown a sensitivity of 98.8% and 93.8% for
Capilia TB-Neo and SD Bioline respectively, and 100% specific-
ity for both assays. Some evaluation studies have reported
sensitivity and specificity of 99.2% and 100% for Capilia TB as-
say, which is in accordance with this study, and thus useful in
rapid differentiation of MTB complex from NTM [10,16]. An-
other study has shown lower sensitivity (92.4%) with Capilia
TB kit [17]. No false positive was observed in this study as re-
ported in earlier studies [16,17].
Although most strains of MTB complex are usually correctly
identified with Capilia, some Capilia TB negative strains have
been isolated elsewhere [18]. In this study, the Capilia TB nega-
tive and SD Bioline negative isolate was later identified by Geno-
type Mycobacterium CM/spoligotyping tests as MTB complex/
Mycobacterium africanum [19]. The failure of Capilia TB to detect
the MPB64 has been previously ascribed to mutation within the
MPB64 gene that led to the production of an incomplete protein
as a result of a deletion of the C-terminal region of the protein
[18]. Although this study did not investigate the reason for this
observation, a similar occurrence may be responsible.
The SD Bioline test is very accurate in detecting MPT64
antigen, although the manufacturer has recognized a low
incidence of false negative results (Sensitivity of 98.6%). The
SD Bioline sensitivity of 93.8% in this study may be partly
due to denaturation of the MPT 64 protein following the appli-
cation of heat to kill the isolates prior to testing and partly to
the use of distilled water rather than the buffer recommended
by the manufacturer. Recent evaluation studies have reported
excellent sensitivities of 100% [20,21], 99% [22,23], and 97.1%
[24]. As in this study, several studies have reported 100% spec-
ificity [20–24].
The 93.8% sensitivity of this study, despite heating of iso-
lates and use of water rather than extraction buffer indicate
that the test performance was not greatly influenced by these
factors. The isolates were heat-killed prior to their transport
to Guadeloupe for molecular analysis.
Capilia and SD Bioline may well be adapted in the identifi-
cation of mycobacterial strains isolated in Nigeria, although
further studies using Capilia on heat-killed organisms are re-
quired. This study confirmed that the methods are fast and
easy to perform with high sensitivity and specificity. These
methods present as more rapid and easier alternatives for
identification of MTB Complex isolates compared with the
more cumbersome traditional ones, such as Niacin, Nitrate
and 68 C Catalase, still currently used in Nigeria.
Although immunochromatographic methods can ascer-
tain that an isolate is a member of the TB complex (sensitiv-
Table 2 – Comparison between the two immunochromato-
graphic methods and the Genotype Mycobacterium CM kit.
Capilia SD Bioline Total
Positive Negative Positive Negative
M.tba
complex
80 1 76 5 81
Hain
Non M.tb
complex
0 16 0 16 16
Total 80 17 76 21 97
a Mycobacterium tuberculosis.
Table 1 – Capilia TB-Neo and SD bioline results of the 97
sputum smear positive in Nigeria.
Capilia TB-Neo/SD Bioline Positive Negative Total
Positive 76 4 80
Negative 0 17 17
Total 76 21 97
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of MPT64 production). Hence, 12 out of the 16 isolates nega-
tive for Capilia and SD Bioline were identified by Hain as
non-mycobacteria despite being isolated from sputum
smear-positive patients.Disclosure
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